drugset / Trial / NCT06580223
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
Phase 3
Not yet recruiting
530 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to evaluate the efficacy and safety of aspirin and rivaroxaban in thromboprophylaxis in Chinese MM patients at high risk for MM-associated VTE.
Timeline
- Start
- 2025-09-01
- Primary completion
- 2027-09-01
- Completion
- 2027-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 100 mg | Oral |
| Subject | Rivaroxaban | Other / unclassified | 10 mg | Oral |